Supplemental Material
Supp. Table 1. Pregnant patients with disseminated coccidioidomycosis
As: Asian, B: Black, L: Latina, Nat Am: Native American, NR: Not reported, PP: Post-Partum, W: White
Case No. First Author/Reference Age (y) R Trimester Sites of Disease Fetal Maternal Outcome No. a Outcome
1 Mendenhall (1) 30 W 1 Pulmonary, probable Died, no Died at 5 mo
meninges, kidney, liver infection gestation
2 Smale (2) 37 B NR Pulmonary, skin, Stillborn Died, day 3 PP
meninges, bone, soft
tissue 3 Smale (2) 28 B 3 Pulmonary, meninges Died, Died, day 1 PP
prematurity
4 Smale (2) 34 B 3 Pulmonary, meninges Healthy, Survived
survived 5 Smale (2) 27 B 3 Pulmonary (miliary), Died, Died, third trimester
spleen undelivered, no
infection
6 Conan (3) 30 W PP Uterine, skin, fungemia Healthy, Died 2 years PP
survived 7 Vaughn (4) 20 B 1 Skin Spontaneous Died
abortion 8 Vaughn (4) 34 L 2 Meninges Healthy, Survived
survived 9 Vaughn (4) 22 B 2 Meninges, skin Died, Died
prematurity, no
infection
1 Odio 2 10 Vaughn (4) 29 W 3 Disseminated, site not Healthy, Died
reported survived 11 Vaughn (4) 31 W 3 Disseminated, site not Healthy, Died
reported survived 12 Vaughn (4) 24 A 3 Meninges Healthy, Died
survived 13 Vaughn (4) 37 B 3 Disseminated, site not Stillborn, no Died
reported infection
14 Vaughn (4) 28 B 3 Disseminated, site not Healthy, Died
reported survived 15 Vaughn (4) 27 B 3 Disseminated, site not Died, no Died, undelivered
reported infection
16 Vaughn (4) 19 B 3 Disseminated, site not Healthy, Died
reported survived 17 Cohen (5) 22 B 2 Pulmonary (miliary), Died, Died, 14 days PP
skin, bone immature, no
infection
18 Cohen (5) 34 B 2 Pulmonary (miliary), Spontaneous Died at childbirth
meninges, skin abortion, no
infection
19 Baker (6) 32 W 3 Pulmonary, meninges, Healthy, Died, 9 days PP
brain parenchyma survived 20 Harrison (7) 20 W 2 Pulmonary, skin, Immature, died Died
meninges 21 Mongan (8) 21 W 2 Pulmonary, liver, Died before Died in second
urinary birth trimester
2 22 Harris (9) 22 W 3 Pulmonary (miliary), Healthy, Died
liver survived 23 Harris (9) 38 W 3 Pulmonary (miliary), Healthy, Died
liver survived 24 Harris (9) 21 B 2 Bone Healthy, Survived
survived 25 Hadsall (10) 38 L 3 Skin Healthy, Survived
survived 26 Hadsall (10) 26 B Skin Spontaneous Survived
abortion;
second
pregnancy
survived
27 Purtilo (11) 22 W 3 Pulmonary, meninges, Immature, died Died
liver 28 VanBergen (12) 27 W 2 Pulmonary (miliary), Healthy, Died
meninges, fungemia survived 29 Steele (13) 17 W Pulmonary, meninges Healthy, Survived
survived 30 Shafai (14) 35 B 3 Pulmonary, Twins died of Died 1 day PP
disseminated infection and
prematurity
31 McCaffree20 (15) 34 N 2 Pulmonary, skin Healthy, Survived
R survived 32 McCaffree20 (15) NR N 3 Meninges Healthy, Survived
R survived 33 Bernstein (16) 32 A 3 Cervix Died of Survived
infection 34 Salgia (17) 33 L Uterine Healthy, Survived
survived 3 Odio 4 35 Wack (18) 28 W 2 Skin Healthy, Survived
survived 36 Wack (18) 26 W Pulmonary, meninges Healthy, Survived
survived 37 Babycos (19) 21 B 3 Pulmonary, skin, bone Born Died PP
marrow, heart prematurely,
healthy, no
infection
38 Lee (20) 19 B 3 Disseminated, No mention of Survived
meninges outcome of first
pregnancy;
second infant
born
prematurely
with
fluconazole-
related defects;
no infection
39 Pursley (21) 22 N 3 Disseminated Four Survived
R pregnancies:
two healthy
and two with
fluconazole
tetragonic
finding 40 Aleck (22) 27 L 3 Meninges Healthy, Survived
survived
4 41 Charlton (23) 20 L 3 Pulmonary, Pneumonia, Died
disseminated to liver, survived
placenta 42 Crum (24) 21 L 3 Pulmonary (miliary), Healthy, Survived
bone, skin survived 43 Arnold (25) 30 L 3 Placenta Healthy, Survived
survived 44 Hooper (26) 27 N 2 Placenta Died Survived
45 Anstead (27) 24 RB 2 Disseminated, site not Died Survived reported 46 Cunningham (28) 31 N 2 Meninges Elective Survived
R abortion 47 Crum (29) 24 A Skin Healthy, Survived
survived 48 Calderon (30) 22 L 3 Meninges Healthy, Died
survived 49 Calderon (30) 23 L 3 Meninges Healthy, Died
survived 50 Calderon (30) 24 L 2 Meninges and CNS Healthy, Died
abscess, survived
lymphadenitis, soft tiss 51 Calderon (30) 27 L 3 Soft Tissue Died Died 52 Peterson (31) 21 B NR Skin Died Survived
5 Odio 6
Supp. Table 2. Patients with exogenous immunosuppression and disseminated coccidioidomycosis
As: Asian, B: Black, L: Latino/a, Nat Am: Native American, NR: Not reported, W: White
Case First Age (Y) Reason for Medication/Dose Reduct Symptom Pulmonar Location of Final No. Author Immunosuppressio ion or improvement < 1 mo y Disease Dissemination Outcome n withdra after reduction or wal of withdrawal of immun immunosuppression osuppr ession 1 Bravo (32) 16 ALL COG AALL0232 protocol Intrathe Y N Appendicular Survived
cal osteomyelitis,
methotr cutaneous,
exate meninges
continu
ed; 5-
day
prednis
one
pulses
were
d/c for 3
months 2 Bravo (32) 20 ALL COG AALL0232 protocol Off N/A N Axial Survived
therapy osteomyelitis,
for 8 cutaneous, soft
months tissue
at time
of 6 fungal
present
ation 3 Bravo (32) 6 Symptomatic Prednisone, 5 day course/ dose NR Y N Y Blood, axial Died
treatment of fatigue, osteomyelitis, soft
fevers, weight loss tissue (2 or more
locations) 4 Blodget 23 Kidney transplant Anti-thymocyte globulin (1 mg/kg daily NR NR Y Blood, soft tissue Survived
(33) for 4 days), tacrolimus 1 mg q 12 h,
MMF 500 mg b.i.d., methylprednisolone
5 Blodget 66 Heart transplant MMF 1500 mg b.i.d., prednisone 10 mg NR, NR Y Blood, soft tissue Died
(33) b.i.d., tacrolimus 2 mg AM and 1 mg PM. died 6 (2 or more
days locations)
after
CM
diagnos
is 6 Blodget 40 Kidney transplant MMF 500mg daily, prednisone 10 mg NR, NR Y Blood, soft tissue Died
(33) daily, tacrolimus 3mg q AM and 4mg q died 5 (2 or more
PM days locations)
after
CM
diagnos
is 7 Dierberg 19 Kidney transplant Tacrolimus, prednisone, MMF/ dose NR NR NR Y Blood Survived
(34) 8 Dierberg 45 Kidney/pancreas Tacrolimus, prednisone, MMF/ dose NR NR, CM NR Y Blood Died
(34) transplant was
diagnos
7 Odio 8 ed
postmor
tem 9 Keckich 49 Kidney transplant Thymoglobulin, tacrolimus, prednisone/ NR NR Y Meninges Survived
(35) dose NR 10 Keckich 64 Liver transplant Tacrolimus, prednisone/ dose NR NR NR Y Soft tissue Survived
(35) 11 Kokseng 18 Kidney transplant MMF, tacrolimus/ dose NR MMF Y N Cutaneous, Survived
(36) d/c, meninges
tacrolim
us dose
decreas
ed 12 Mitter (37) 50 Crohn’s disease 100 mg 6-mercaptopurine daily, Both N Y Appendicular Died
adalimumab/ dose NR were osteomyelitis,
d/c cutaneous,
meninges and
CNS abscess,
soft tissue 13 Carvalho 62 Kidney transplant Cyclosporine and prednisolone/ dose Doses N N CNS abscess Died
(38) NR of both
were
reduced 14 Keckich 74 Type of malignancy Steroids/ dose NR NR NR Y Blood Survived
(39) NR 15 Keckich 79 Rheumatoid arthritis Azathioprine/ dose NR NR NR Y Blood Died
(39) 16 Keckich 66 Dermatomyositis Steroids/ dose NR NR NR Y Blood Survived
(39) 17 Trentman 37 Sarcoidosis Prednisone/ dose NR NR NR N Appendicular Survived
(40) osteomyelitis,
8 cutaneous
18 Wollina 52 Sarcoidosis Prednisolone and methotrexate (MTX) / Both Y Y Cutaneous Survived
(41) dose NR were
d/c 19 Stagliano 3 Wilms' tumor Chemotherapy for tumor/ medications No N/A Y Blood, cutaneous, Survived
(42) and doses NR soft tissue 20 Kappel 48 HIV N/A Viral N/A Y Cutaneous Survived
(43) load
and
CD4
count
were
NR 21 Assi (44) 64 Liver transplant Corticosteroids/ dose NR NR NR Y Appendicular Survived
osteomyelitis 22 Sohail (45) 72 Arachnoiditis Dexamethasone/dose NR NR NR Y Soft tissue Died of
other
cause 23 Sohail (45) 56 Kidney transplant Prednisone, azathioprine, cyclosporine/ NR NR Y Soft tissue Died of
dose NR other
cause 24 Ugurlu (46) 77 Suspected giant cell High dose prednisone/ dose NR Prednis NR N Cutaneous, soft Survived
arteritis one tissue
D/C 25 Wang (47) 71 Intermittent fever Prednisolone/ 30 mg/day NR NR Y Blood, meninges Died 26 Glenn (48) 42 GVHD prophylaxis Cyclosporine methotrexate/ dose NR No N/A Y Axial Died of
and control after Prednisone/ 120 mg/day osteomyelitis, other
HSCT for chronic blood, cause
myelogenous lymphadenitis,
leukemia soft tissue (2 or 9 Odio 10 more locations)
27 Blair (49) 60 Kidney transplant Prednisone 15 mg daily, tacrolimus 2 mg NR NR Y Appendicular Survived
b.i.d, MMF 1 g b.i.d. osteomyelitis, soft
tissue 28 Lewicky 36 Presumed Prednisone 15 mg daily Prednis N Y Axial Survived
(50) sarcoidosis one d/c osteomyelitis, soft
tissue (2 or more
locations) 29 Miller (51) 61 Lung transplant Methylprednisone, azathioprine, and NR NR Y Soft tissue (2 or Died
cyclosporine/ dose NR more locations) 30 Kuberski 57 Presumed Prednisone/ dose NR NR NR Y Axial Survived
(52) costochondritis osteomyelitis 31 Antony 75 Unrelenting Prednisone taper over several weeks Prednis N Y Axial Survived
(53) exophthalmos starting at 60 mg daily one d/c osteomyelitis 32 Wright (54) 46 Liver transplant Regimen and dose NR NR NR Y Axial Died
osteomyelitis,
CNS abscess,
soft tissue (2 or
more locations) 33 Wright (54) 28 Kidney transplant Regimen and dose NR NR NR Y Axial Died
osteomyelitis,
CNS abscess,
soft tissue (2 or
more locations) 34 Yorgin (55) 13 Lupus nephritis Pulse cyclophosphamide/ 500 mg/m2, NR NR Y CNS abscess, Died
daily steroids/ dose NR lymphadenitis,
soft tissue (2 or
more locations)
10 35 Fishco (56) 40 Sarcoidosis Prednisone, 10 mg and 20 mg on NR NR N Appendicular Survived
alternate days osteomyelitis
36 Erly (57) 74 Waldenström's Steroid therapy for 2 years and NR NR Y Axial Died
macroglobulinemia intermittent chemotherapy for 5 years/ osteomyelitis, soft
dose NR tissue (2 or more
locations) 37 Smilack 72 Pulmonary Varying doses of prednisone for 5.5 Prednis N Y Axial Survived
(58) sarcoidosis years/ doses NR one d/c osteomyelitis,
cutaneous, soft
tissue (2 or more
locations) 38 Banuelos 50 Liver transplant Azathioprine, prednisone, tacrolimus/ NR NR Y Axial Survived
(59) dose NR osteomyelitis,
CNS abscess and
meninges 39 Wagner 34 Non-Hodgkin's Two courses of ONCEP, one course of Immuno N Y Axial Died
(60) lymphoma ESHAP/ doses NR suppres osteomyelitis
sive
therapy
was
delayed 40 Mischel 30 HIV No ART given CD4 N/A/ diagnosed Y CNS abscess and Died
(61) count postmortem meninges
80/ μL 41 Gold (62) 36 HIV Treated with zidovudine CD4 N/A Y Cutaneous, Died
count lymphadenitis,
7/μL meninges, soft
tissue (2 or more
locations)
11 Odio 12 42 Zar (63) 28 HIV No ART given CD4 N/A N Axial Survived
count osteomyelitis,
576/μL blood, meninges,
soft tissue 43 Dodd (64) 60 Liver transplant Prednisone and cyclosporine/ doses NR NR NR Y Soft tissue Died 44 Byrne (65) 57 HIV No ART given CD4 N/A Y Blood, meninges, Died of
count soft tissue other
10/ μL cause 45 Prichard 28 HIV No ART given CD4 N/A Y Axial Died
(66) count osteomyelitis,
NR cutaneous 46 Vartivarian 29 Heart transplant Cyclosporine, 400 mg daily, rabbit Prednis Patient died <1 mo Y Axial Died
(67) antithymocyte globulin, 500 mg one after infection osteomyelitis,
intramuscular daily, and prednisone 60 was presentation; CM blood, cutaneous,
mg daily. tapered diagnosed postmortem soft tissue (2 or
to 5 more locations)
mg/day 47 Ampel (68) 20 Kidney transplant Azathioprine 150 mg daily, prednisone Both Y but later relapsed Y Blood, soft tissue Died
25 mg daily were
reduced 48 Ampel (68) 83 Chronic lymphocytic Dexamethasone 24 mg daily NR NR Y Blood Died
leukemia 49 Ampel (68) 6 Lymphoblastic Dexamethasone 3 mg daily NR NR Y Blood Died
lymphoma 50 Ampel (68) 81 Chronic lymphocytic Prednisone 10 mg daily NR NR Y Blood, soft tissue Died
leukemia 51 Ampel (68) 63 Bacterial Dexamethasone 16 mg daily NR NR Y Blood Died
osteomyelitis 52 Ampel (68) 54 Breast carcinoma Prednisone 5 mg daily NR NR Y Blood, soft tissue Died 53 Ampel (68) 68 Large cell carcinoma Dexamethasone 16 mg daily NR NR Y Blood Died
of lung; squamous
cell carcinoma of the 12 hypopharynx 54 Ampel (68) 24 HIV ART NR CD4 NR Y Blood Survived
count
NR 55 Ampel (68) 62 Chronic lung disease; Prednisone 25 mg daily NR NR Y Blood Died
Idiopathic
cardiomyopathy 56 Ampel (68) 46 Chronic lung disease Prednisone 70 mg daily NR NR Y Blood Survived 57 Ampel (68) 71 Glioblastoma Dexamethasone 4 mg t.i.d. NR NR Y Blood Died 58 Ampel (68) 58 HIV ART NR CD4 N/A Y Blood Died
count
NR 59 Ampel (68) 32 HIV No ART given CD4 N/A Y Blood Died
count
NR 60 Wolf (69) 36 HIV No ART given CD4 N/A N Cutaneous, Survived
count lymphadenitis,
6.1 K soft tissue 61 Parker (70) 30 Lupus nephritis Prednisone 200 mg daily, Prednis Y Y Axial Survived
cyclophosphamide 300 mg daily one osteomyelitis, soft
was tissue
tapered 62 Abrams 30 HIV No ART given CD4 N/A Y Axial Died
(71) count osteomyelitis,
2.7 K blood,
lymphadenitis,
soft tissue (2 or
more locations) 63 Kovacs 30 HIV No ART given CD4 N/A Y Lymphadenitis, Died of
(72) count soft tissue other
2.9 K cause
13 Odio 14 64 Howard 39 Kidney transplant Prednisone 40 mg daily, azathioprine NR NR, patient died 1 Y Soft tissue Died
(73) 125 mg daily week after
hospitalization for
infection 65 Howard 32 Lupus nephritis Prednisone 5 mg daily NR NR Y Axial Survived
(73) osteomyelitis,
blood, meninges,
soft tissue (2 or
more locations) 66 Brewer 51 Heart transplant Azathioprine, methylprednisone, NR NR Y CNS abscess, Died
(74) antilymphocyte globulin/ doses NR soft tissue (2 or
more locations) 67 MacDonald 5.5 ALL Monthly doses of vincristine sulfate (1.5 All Y Y Cutaneous, Survived
(75) mg intravenously), prednisone (40 immuno lymphadenitis
mg/day for 5 days), weekly oral doses of suppres
methotrexate (20 mg per dose), and sives
daily doses of mercaptopurine (75 mg) were
held 68 Allen (76) 66 Emphysema Prednisone/ 35 mg daily No Died three days after Y Soft tissue (2 or Died
CM diagnosed and more locations)
antifungals given 69 Gardner 1 Rhinitis, stridor and Dexamethasone/ dose NR D/C Y Y Soft tissue Survived
(77) cough unresponsive
to antibiotics 70 Kaplan 20 Kidney transplant Prednisone 30 mg every other day, Both Y Y Cutaneous, Survived
(78) azathioprine, 50 mg daily. were meninges, soft
d/c tissue 71 Davis (79) 32 Presumed pulmonary Steroids/ dose NR D/C N Y Meninges Survived
sarcoidosis
14 72 Halpern 23 Sarcoidosis Steroids/ dose NR NR NR Y Axial Survived
(80) osteomyelitis,
lymphadenitis,
soft tissue (2 or
more locations) 73 Harvey 23 Lupus nephritis Prednisone 60 mg daily Tapere N N Axial Survived
(81) d to osteomyelitis, soft
12.5 tissue
mg/day 74 Schroter 44 Kidney transplant Prednisone 200 mg daily, azathioprine N CM Diagnosed Y Lymphadenitis, Died
(82) 150 daily postmortem soft tissue (2 or
more locations) 75 Lee (83) 48 Kidney transplant Prednisone 20 mg daily; azathioprine NR NA Y Cutaneous Survived
150 mg
76 Krulig (84) 57 Pemphigus vulgaris Betamethasone 12 mg daily, N CM Diagnosed Y Axial Died
azathioprine 200 mg daily postmortem osteomyelitis,
lymphadenitis,
soft tissue (2 or
more locations) 77 Deresinski 32 Hodgkin’s lymphoma Prednisone 40 mg daily NR CM diagnosed Y Axial Died
(85) postmortem osteomyelitis,
lymphadenitis,
meninges, soft
tissue (2 or more
locations) 78 Deresinski 16 Hodgkin’s lymphoma MOPP NR Patient died 9 days Y Axial Died
(85) after nodules appeared osteomyelitis,
lymphadenitis,
soft tissue (2 or
15 Odio 16 more locations)
79 Deresinski 37 Hodgkin’s lymphoma MOP MOP N; died 6 months after N Meninges Died
(85) D/C CM diagnosis despite
antifungals
16 Supp Table 3. Demographic information of patients with exogenous immune suppression and disseminated coccidioidomycosis
*Other: Native American (2), Not reported (19)
Total Survived Died Death from other cause Total, n (%) 79 35 (44) 39 (49) 5 (6) Age, years, median (IQR) 44 (28 – 62) 36 (23 – 57) 46 (30 – 63) 56 (36 – 65) Gender, Male, n (%) 59 (75) 23 (66) 31 (79) 5 (100) Race, n (%) Black 9 (11) 6 (17) 3 (8) 0 (0) White 29 (37) 13 (37) 16 (41) 0 (0) Asian 3 (4) 2 (6) 1 (3) 0 (0) Latino 16 (20) 3 (9) 11 (28) 2 (40) *Other 22 (28) 11 (31) 8 (21) 3 (60) Immune suppression Cause, n(%) Transplant regimen 24 (30) 9 (26) 13 (33) 2 (40) Isolated steroid therapy 29 (37) 16 (46) 12 (31) 1 (20) Cancer chemotherapy 8 (10) 4 (11) 4 (10) 0 (0) HIV 12 (15) 4 (11) 6 (15) 2 (40) Regimens for autoimmune 6 (8) 2 (6) 4 (10) 0 (0)
disease Site of dissemination, n (%) Pulmonary disease 68 (86) 26 (74) 37 (95) 5 (100) Osteomyelitis 29 (37) 16 (46) 12 (31) 1 (20) Axial 23 (29) 11 (31) 11 (28) 1 (20) Appendicular 6 (8) 5 (14) 1 (3) 0 (0) CNS Infection 20 (25) 8 (23) 11 (28) 1 (20) Meningitis 12 (15) 7 (20) 4 (10) 1 (20) Abscess 5 (6) 0 (0) 5 (13) 0 (0) Meningitis and 3 (4) 1 (3) 2 (5) 0 (0)
abscess Lymphadenitis 12 (15) 3 (9) 7 (18) 2 (40) Cutaneous 17 (22) 13 (37) 4 (11) 0 (0) Soft tissue 44 (56) 16 (46) 23 (59) 5 (100) 2 or more locations 22 (28) 4 (11) 17 (44) 1 (20) Blood 29 (37) 8 (23) 21 (54) 0 (0) Year Published, n (%) 2000 - 2013 35 (44) 20 (57) 12 (31) 3 (60) 1990 - 1999 8 (10) 3 (9) 5 (13) 0 (0) 1980 - 1989 27 (34) 8 (23) 17 (44) 2 (40) 1970 - 1979 9 (11) 4 (11) 5 (13) 0 (0) 17 Odio 18
Supp. Table 4. Location of coccidioidomycosis dissemination by racial group in patients with exogenous immunosuppression.
*Other: Native American (2), Not reported (19)
Total, n (%) Black White Latino Asian *Other
Total, n 79 9 29 16 3 22 Pulmonary disease 68 (86) 9 (100) 25 (86) 14 (88) 2 (67) 18 (82) Osteomyelitis 29 (37) 4 (44) 7 (24) 7 (44) 1 (33) 10 (45) Axial 23 (29) 4 (44) 6 (21) 7 (44) 1 (33) 5 (23) Appendicular 6 (8) 0 (0) 1 (3) 0 (0) 0 (0) 5 (23) CNS 20 (25) 3 (33) 6 (21) 4 (25) 2 (67) 5 (23) Meningitis 12 (15) 2 (22) 3 (10) 2 (13) 2 (67) 3 (14) Abscess 5 (6) 1 (11) 3 (10) 0 (0) 0 (0) 1 (5) Meningitis and 3 (4) 0 (0) 0 (0) 2 (13) 0 (0) 1 (5)
abscess Lymphadenitis 12 (15) 1 (11) 4 (14) 5 (31) 0 (0) 2 (9) Cutaneous lesions 17 (22) 0 (0) 7 (24) 1 (6) 1 (33) 8 (36) Soft Tissue 44 (56) 4 (44) 15 (52) 10 (63) 0 (0) 15 (68) 18 2 or more locations 22 (28) 4 (44) 7 (24) 5 (31) 0 (0) 6 (27) Blood 29 (37) 3 (33) 17 (59) 5 (31) 1 (33) 3 (14)
19 Odio 20 Supp. Table 5. Patients with multi-site disseminated coccidioidomycosis (MDCM)
As: Asian, B: Black, L: Latino/a, Nat Am: Native American, NR: Not reported, W: White
A: Amphotericin, C: Caspofungin, D: Difulcan, F: Fluconazole, I: Itraconazole, K: Ketoconazole, LA: Liposomal amphotericin, M: Miconazole, P: Posaconazole, V: Voriconazole
Case First Author Age Rac Sex PMH Pulmonary disease Location Antifungal Surgery Abscess/ No. of Final No. (Y) e of s Used Fluid Relapses Outcome Dissemina Drainage tion 1 Fierer (86) 52 B M Other N Cutaneous LA, F, P N N 0 Survived
illness , soft
tissue 2 Duplessis (87) 30 B M Other Y Axial/ LA, P, IFN- N N 0 Survived
infection appendicul γ
ar
osteomyeli
tis 3 Duplessis (87) 23 B M None N Axial LA, I, P, Y N 0 Survived
osteomyeli IFN- γ
tis
(multiple
locations) 4 Silva- 20 L M Other Y Cutaneous LA, F N N 1 Death
Hernandez infection , soft from other
(88) tissue causes 5 Keckich (39) 70 W M Other Y Blood, F N N 0 Survived
illness Meninges,
soft tissue 6 Keckich (39) 63 B M Other Y Blood, Soft F N N 0 Survived
illness tissue (2 or
more
locations) 7 Keckich (39) 47 W M Other Y Blood 20 illness 8 Kwok (89) 50 NR M None Y Cutaneous F N N 0 Survived
,
lymphaden
itis 9 Kwok (89) 42 NR M Other N Axial A, F N N 0 Death
infection/ osteomyeli from other
Other tis, soft causes
illness tissue 10 Wilde (90) 42 B F Other Y Axial A, F N N 1 Death
illness osteomyeli from other
tis, soft causes
tissue 11 Nolt (91) 0 NR M Other Y CNS F N N 0 Survived
infection abscess,
lymphaden
itis 12 Crum- 19 L F None Y Lymphade LA, F Y Y 0 Survived
Cianflone (92) nitis, soft
tissue 13 Crum- 31 B M Other Y Cutaneous LA, F Y Y 0 Survived
Cianflone (92) illness ,
lymphaden
itis, soft
tissue 14 Crum- 65 As M Other Y Appendicul LA, F N Y 0 Survived
Cianflone (92) illness ar
osteomyeli
tis, soft
tissue 15 Rosendahl (93) 32 W M None Y CNS F N N 1 Survived
21 Odio 22 abscess,
cutaneous 16 Crum (94) 59 L F Other Y Axial LA, I N N 0 Survived
illness osteomyeli
tis,
cutaneous,
lymphaden
itis 17 Anstead (27) 17 B F None Y Osteomyeli LA, F, P, Y Y 1 Died
tis V, C, IFN-γ
unspecifie
d location,
cutaneous,
soft tissue 18 Anstead (27) 20 B M None Y Axial and A, LA, F, I, N N 1 Survived
appendicul K, P
ar
osteomyeli
tis,
cutaneous 19 La Via (95) 10 L M Other Y Meninges, A, LA, F, I Y N 1 Survived
illness soft tissue
(2 or more
locations) 20 Biller (96) 24 B F None Y Axial LA, F, V N Y 0 Survived
osteomyeli
tis, CNS
abscess,
lymphaden
itis 22 21 Prabhu (97) 31 B M None Y Axial and A, LA, F, I, N N 1 Survived
appendicul V, C
ar
osteomyeli
tis, soft
tissue 22 Arnold (98) 17 As F None Y Axial and A, F N N 0 Survived
appendicul
ar
osteomyeli
tis,
cutaneous 23 Arnold (98) 29 As M None Y Axial A, F N N 0 NR
osteomyeli
tis,
cutaneous,
soft tissue 24 Baddley (99) 28 B F None N Axial A, LA, F N Y 0 Survived
osteomyeli
tis,
cutaneous,
soft tissue 25 Crum and 20 L M None N Axial and A, I N N 0 Survived
Lederman (29) appendicul
ar
osteomyeli
tis, soft
tissue 26 Crum and 21 B M None Y Axial A, LA, I N N 1 Survived
Lederman (29) osteomyeli 23 Odio 24 tis, soft
tissue 27 Crum and 22 B M None Y Axial and A, I N N 0 Survived
Lederman (29) appendicul
ar
osteomyeli
tis,
cutaneous 28 Crum and 59 L F None Y Axial A, F, I N N 0 Survived
Lederman (29) osteomyeli
tis,
cutaneous 29 Crum and 25 L F None Y Appendicul A, F N N 1 Survived
Lederman (29) ar
osteomyeli
tis,
cutaneous,
lymphaden
itis 30 Crum and 23 B M None Y Axial A, I N N 0 Survived
Lederman (29) osteomyeli
tis,
cutaneous 31 Crum and 29 As M None N Axial A, I N N 1 Survived
Lederman (29) osteomyeli
tis,
cutaneous,
lymphaden
itis 32 Crum and 36 B M None N Axial and A, F N N 0 Survived
24 Lederman (29) appendicul
ar
osteomyeli
tis 33 Crum and 49 As F None Y Cutaneous F N N 1 Survived
Lederman (29) ,
lymphaden
itis 34 Crum and 52 W M None Y Axial and A, F, I N N 0 Survived
Lederman (29) appendicul
ar
osteomyeli
tis ,
cutaneous 35 Crum and 35 L M None N Axial F N N 0 Survived
Lederman (29) osteomyeli
tis,
cutaneous,
meninges 36 Crum and 42 As M Other Y Axial A, F, I N N 0 Survived
Lederman (29) illness osteomyeli
tis,
cutaneous,
soft tissue 37 Crum and 40 As F None Y Lymphade F N N 0 Survived
Lederman (29) nitis, soft
tissue 38 Crum and 45 As M None N Cutaneous A, F N N 2 Survived
Lederman (29) , meninges
and CNS
25 Odio 26 abscess,
lymphaden
itis 39 Crum and 52 As M None N Cutaneous A, F Y Y 2 Survived
Lederman (29) , meninges 40 Danaher (100) 20 B M NR Y Axial and A, LA, F, P Y N 3 Survived
appendicul
ar
osteomyeli
tis,
cutaneous,
soft tissue 41 Crum (94) 22 B M None Y Axial and LA N N 0 Survived
appendicul
ar
osteomyeli
tis,
cutaneous 42 Crum (94) 59 L F None Y Axial A, I N N 0 Survived
osteomyeli
tis,
cutaneous 43 Crum (94) 19 As M None N Axial and A N Y 0 Survived
appendicul
ar
osteomyeli
tis, soft
tissue 44 Crum (94) 21 B M None Y Axial A, I Y N N/A Survived
osteomyeli
26 tis, soft
tissue (2 or
more
locations) 45 Crum (94) 21 B M NR Y Axial A, I Y N N/A Survived
osteomyeli
tis,
lymphaden
itis, soft
tissue 46 Holley (101) 32 NR M NR N Axial A, I N N 0 Survived
osteomyeli
tis, soft
tissue 47 Erly (57) 33 NR M None N Meninges F N N 1 Died
and CNS
abscess,
soft tissue 48 Polesky (102) 41 B F None N Lymphade A, F, I N N 4 Survived
nitis, soft
tissue 49 Polesky (102) 48 Paki M Other Y Cutaneous A, F, I N N 1 Survived
stan illness ,
i lymphaden
itis, soft
tissue 50 Koehler (103) 32 As M None Y Osteomyeli A, LA, F, I, N N 0 Survived
tis K
(unspecifie
d location),
27 Odio 28 cutaneous,
lymphaden
itis, soft
tissue 51 Cunningham 32 B M None Y Axial and A, F N N N/A NR
(28) appendicul
ar
osteomyeli
tis,
cutaneous,
soft tissue 52 Westphal (104) 25 NR M NR N Axial A, F N N 2 Died
osteomyeli
tis,
cutaneous 53 Herron (105) 34 B M NR N Axial A Y Y 0 Survived
osteomyeli
tis, soft
tissue 54 Woo (106) 63 NR F None Y Cutaneous A N N 0 Died
,
lymphaden
itis, soft
tissue (2 or
more
locations) 55 Banuelos (59) 45 L M Other Y Osteomyeli A Y N 1 Died
illness tis
(unspecifie
d location), 28 meninges
and CNS
abscess,
soft tissue 56 Banuelos (59) 21 W M Other Y Axial A, F Y N 0 Survived
illness osteomyeli
tis, CNS
abscess,
soft tissue 57 Banuelos (59) 63 W M Other Y Lymphade A, F N N 1 Died
illness nitis,
meninges
and CNS
abscess,
soft tissue
(2 or more
locations) 58 Olson (107) 27 B M Other N Axial A N N 0 Survived
infection osteomyeli
tis, soft
tissue (2 or
more
locations) 59 Olson (107) 27 As M NR Y Appendicul A, F N Y 1 Survived
ar
osteomyeli
tis,
cutaneous,
lymphaden
29 Odio 30 itis 60 Oudiz (108) 24 As M Other Y Lymphade None N Y 0 Died
illness nitis, soft
tissue (2 or
more
locations) 61 Hicks (109) 24 B M None Y Cutaneous A, K N N 0 Survived
,
lymphaden
itis, soft
tissue 62 Beard (110) 25 B M None Y Axial A, F N N 0 Survived
osteomylei
tis,
cutaneous,
soft tissue 63 Lopez (111) 70 NR M NR Y Lymphade A N N 0 Died
nitis, soft
tissue 64 Lopez (111) 65 NR M Other N Soft tissue None N N 0 Died
illness (2 or more
locations) 65 Schwartz (112) 71 W M Other Y Meninges, A, F, K N N 1 Survived
illness soft tissue
(2 or more
locations) 66 Chen (113) 28 As M None Y Cutaneous F N N 1 Survived
,
lymphaden
itis 67 Jitsukawa 39 As M Other Y Axial I, M N N 2 Survived
30 (114) illness osteomyeli
tis,
cutaneous,
soft tissue 68 Ampel (68) 19 W M None Y Blood, Soft A N N 0 Survived
tissue (2 or
more
locations) 69 Ampel (68) 23 B M None N Blood, A N N 0 Survived
Cutaneous
, soft
tissue 70 Gillespie (115) 1 B M None N Axial and A, I, K Y N 0 Survived
appendicul
ar
osteomyeli
tis, soft
tissue 71 Weisman (116) 21 W M None N Lymphade A, I, K Y Y 2 Survived
nitis, soft
tissue (2 or
more
locations) 72 Parker (70) 37 NR M NR Y Axial A N N 0 Survived
osteomyeli
tis,
cutaneous,
meninges 73 Howard (73) 19 W M None Y Blood, Soft A N N 0 Survived
tissue (2 or
31 Odio 32 more
locations) 74 Meyer (117) 44 W M Other Y Cutaneous A Y Y 4 Died
infection , meninges
and CNS
abscess,
lymphaden
itis, soft
tissue (2 or
more
locations) 75 Burch (118) 35 B M None N Axial A N N 1 Death
osteomyeli from other
tis, causes
cutaenous 76 Johnson (119) 39 NR F Other N Appendicul A N Y 0 Died
illness ar
osteomyeli
tis,
meninges
and CNS
abscess,
soft tissue 77 Blumenkranz 57 W M None Y Meninges, A, K, M N N 0 Survived
(120) soft tissue 78 Blumenkranz 48 L M Other Y Meninges, A, K N N 0 Death
(120) infection/ soft tissue from other
Other causes
illness 79 Blumenkranz 40 Nat M NR Y Meninges, A, M N Y 2 Survived
32 (120) Am soft tissue 80 McGahan 26 B M Other N Axial A N N 0 Survived
(121) illness osteomyeli
tis,
cutaneous 81 McGahan 21 B M NR Y Axial and A, M N N 1 Survived
(121) appendicul
ar
osteomyeli
tis,
lymphaden
itis, soft
tissue 82 McGahan 20 L M NR N Axial and A N N 0 NR
(121) appendicul
ar
osteomyeli
tis,
cutaneous,
lymphaden
itis soft
tissue 83 McGahan 62 B M NR N Axial A N N 0 Died
(121) osteomyeli
tis, soft
tissue 84 Graybill (122) 73 NR F Other Y Axial A, K, M N N 2 Death
illness osteomyeli from other
tis, causes
cutaneous, 33 Odio 34 soft tissue 85 Graybill (122) 28 L M NR Y Axial and A, K, M N N 4 Survived
appendicul
ar
osteomyeli
tis,
lymphaden
itis,
meninges,
soft tissue 86 Goldstein (123) 35 W M Other Y Lymphade A N N 0 Died
illness nitis,
meninges,
soft tissue
(2 or more
locations) 87 Meyer (124) 51 B M NR N Axial and A, M N Y 2 Survived
appendicul
ar
osteomyeli
tis,
cutaneous,
soft tissue
(2 or more
locations) 88 Meyer (124) 54 B M NR Y Axial and A, M N Y 1 Survived
appendicul
ar
osteomyeli
34 tis, soft
tissue 89 Meyer (124) 52 W M Other Y Axial and A, M Y Y 0 Death
illness appendicul from other
ar causes
osteomyeli
tis,
cutaneous,
lymphaden
itis,
meninges
and CNS
abscess,
soft tissue
(2 or more
locations) 90 Meyer (124) 54 B M NR Y Axial A, M N N 3 Died
osteomyeli
tis,
cutaneous,
lymphaden
itis,
meninges,
soft tissue 91 Meyer (124) 34 B M None Y Meninges, A, M Y Y 0 Died
soft tissue 92 Danoff (125) 40 NR M Other Y Cutaneous A, M Y N 5 Died
illness ,
lymphaden
35 Odio 36 itis,
meninges 93 Harvey (81) 43 W M NR Y Lymphade A Y Y 2 Survived
nitis, soft
tissue 94 Lee (83) 31 NR M NR Y Axial and A, M N N 0 Died
appendicul
ar
osteomyeli
tis,
meninges 95 Thadepalli 26 B M NR Y Osteomyeli A Y N 2 Survived
(126) tis
(unspecifie
d location),
meninges,
soft tissue 96 Armbuster 33 W M NR Y Axial and A, M N N 0 Survived
(127) appendicul
ar
osteomyeli
tis,
cutaneous,
meninges 97 Armbuster 30 B M NR Y Axial and A N N 0 Survived
(127) appendicul
ar
osteomyeli
tis,
cutaneous, 36 lymphaden
itis 98 Kaplan (128) 36 W M Other N Axial A N N 1 Survived
infection osteomyeli
tis,
cutaneous,
lymphaden
itis 99 Sung (129) 50 B M None N Axial A, M N Y 1 Survived
osteomyeli
tis,
cutaneous,
soft tissue 100 Winter (130) 27 B M NR Y Axial and A Y N 1 Survived
appendicul
ar
osteomyeli
tis,
meninges,
soft tissue
37 Odio 38
Supp. Table 6. Demographic information of patients with multi-site disseminated coccidioidomycosis (MDCM)
*Other: Native American (1), Pakistani (1), Not reported (14)
$Time to outcome is days to final follow-up with patients in published reports. It typically represented time from presentation of disseminated coccidioidomycosis symptoms to cure, death, follow-up on long-term antifungals, or termination of antifungal therapy.
Total Survived Died Death from other Outcome Not cause Reported Total, n 100 72 18 7 3 Age, years, median (IQR) 33 (23 – 48) 30 (22 - 45) 42 (33 – 62) 42 (35 - 52) 29 (20 – 32) Gender, Male, n (%) 84 (84) 61 (85) 15 (83) 5 (71) 3 (100) Race, n (%) Black 39 (39) 32 (44) 4 (22) 2 (29) 1 (33) White 17 (17) 12 (17) 4 (22) 1 (14) 0 (0) Latino 13 (13) 9 (13) 1 (6) 2 (29) 1 (33) Asian 15 (15) 13 (18) 1 (6) 0 (0) 1 (33) *Other 16 (16) 6 (8) 8 (44) 2 (29) 0 (0) Location of Dissemination, n (%) Pulmonary disease 71 (71) 51 (71) 13 (72) 5 (71) 2 (67) Osteomyelitis 62 (62) 47 (65) 7 (39) 5 (71) 3 (100) Axial 31 (31) 23 (32) 3 (17) 4 (57) 1 (33) Appendicular 4 (4) 3 (4) 1 (6) 0 (0) 0 (0) Axial/ Appendicular 23 (23) 19 (26) 1 (6) 1 (14) 2 (67) Unspecified location 4 (4) 2 (3) 2 (11) 0 (0) 0 (0) Central Nervous System 29 (29) 17 (24) 10 (56) 2 (29) 0 (0) Meninges 18 (18) 12 (17) 5 (28) 1 (14) 0 (0) Brain abscess 4 (4) 4 (6) 0 (0) 0 (0) 0 (0) Meninges and 7 (7) 1 (1) 5 (28) 1 (14) 0 (0)
abscess Lymphadenitis 34 (34) 24 (33) 8 (44) 1 (14) 1 (33) Cutaneous lesions 52 (52) 38 (53) 6 (33) 5 (71) 3 (100) Soft Tissue 66 (66) 43 (60) 14 (78) 6 (86) 3 (100) 2 or more tissues 15 (15) 8 (11) 6 (33) 1 (14) 0 (0) Blood 6 (6) 5 (7) 1 (6) 0 (0) 0 (0) Number of antifungals given, 2 (1 - 2) 2 (1 - 3) 1 (1 - 2) 2 (2 - 2) 2 (1 - 2) median (IQR) Given 1 yr or more of medication, n 51 (51) 42 (58) 6 (33) 3 (43) 0 (0)
(%) Surgery, n (%) 21 (21) 15 (21) 5 (28) 1 (14) 0 (0) Abscess/ fluid drainage, n (%) 21 (21) 15 (21) 5 (28) 1 (14) 0 (0) Relapse, n (%) 40 (41) 28 (40) 8 (44) 4 (57) 0 (0) Time to outcome (days)$, median 365 (188 – 730) 365 (270 - 730) 296 (40 – 1186) 480 (210 – 545) N/A
38 (IQR) Past medical history, n (%) No significant history 45 (45) 38 (53) 4 (22) 1 (14) 2 (66) Other Infection 6 (6) 4 (6) 1 (6) 1 (14) 0 (0) Other Illness 24 (24) 13 (18) 8 (44) 3 (43) 0 (0) Other infection/ other 2 (2) 0 (0) 0 (0) 2 (29) 0 (0)
Illness Not Reported 23 (23) 17 (24) 5 (28) 0 (0) 1 (33)
Supp. Table 7: Location of coccidioidomycosis dissemination in each racial group in patients with multi-site disseminated coccidioidomycosis (MDCM)
*Other: Native American (1), Pakistani (1), Not reported (14)
Total, n (%) Black White Latino Asian *Other
Total, n 100 39 17 13 15 16 Pulmonary disease 71 (71) 25 (64) 15 (88) 10 (77) 11 (73) 10 (63) Osteomyelitis 62 (62) 32 (82) 5 (29) 9 (69) 9 (60) 7 (44) Axial 31 (31) 16 (41) 2 (12) 4 (31) 4 (27) 5 (31) Appendicular 4 (4) 0 (0) 0 (0) 1 (8) 2 (13) 1 (6) Axial/ Appendicular 23 (23) 14 (36) 3 (18) 3 (23) 2 (13) 1 (6) Unspecified 4 (4) 2 (5) 0 (0) 1 (8) 1 (7) 0 (0)
location Central Nervous System 29 (29) 5 (13) 10 (59) 5 (38) 2 (13) 7 (44) Meninges 18 (18) 4 (10) 5 (29) 4 (31) 1 (7) 4 (25) Brain abscess 4 (4) 1 (3) 2 (12) 0 (0) 0 (0) 1 (6) Meninges and 7 (7) 0 (0) 3 (18) 1 (8) 1 (7) 2 (13)
abscess Lymphadenitis 34 (34) 8 (21) 7 (41) 5 (38) 8 (53) 6 (38) Cutaneous lesions 52 (52) 20 (51) 6 (35) 8 (62) 11 (73) 7 (44) Soft Tissue 66 (66) 28 (72) 12 (71) 8 (62) 8 (53) 10 (63) 2 or more tissues 15 (15) 3 (8) 8 (47) 1 (8) 1 (7) 2 (13) Blood 6 (6) 2 (5) 4 (24) 0 (0) 0 (0) 0 (0)
39 Odio 40
Supp. Table 8. Patients with single site disseminated coccidioidomycosis (SDCM).
Case First Author Age (Y) Race Gende Location of Dissemination Final Outcome No. r 1 Arora (131) 44 Black Male Axial osteomyelitis Survived 2 Kumar (132) 68 NR Male Appendicular osteomyelitis Survived 3 Newlon (133) 45 Black Male Cutaneous Survived 4 Evans (134) 36 Black Male Soft tissue Survived 5 Reach (135) 28 Black Female Axial osteomyelitis Survived 6 Gaidici (136) 37 NR Female Lymphadenitis Survived 7 Crum-Cianflone (92) 61 Asian Male Soft tissue Survived 8 Park (137) 31 Asian Male Cutaneous Survived 9 Hwang (138) 53 White Male Meningitis Survived 10 Chuang (139) 34 Asian Male Cutaneous Survived 11 Sohail (45) 61 NR Male Soft tissue Survived 12 Sohail (45) 82 NR Male Soft tissue Survived 13 Sohail (45) 84 NR Male Soft tissue Survived 14 Sohail (45) 68 NR Male Soft tissue Survived 15 Snyder (140) 66 White Female Meningitis Survived 16 Rodriguez (141) 56 Latino Male Soft tissue Survived 17 Crum (29) 25 Asian Male Cutaneous Survived 18 Crum (29) 17 Black Male Appendicular osteomyelitis Survived 19 Crum (29) 75 Black Male Axial osteomyelitis Survived 20 Crum (29) 21 Black Male Axial osteomyelitis Survived 21 Crum (29) 47 Asian Male Soft tissue Survived 22 Crum (29) 27 Black Male Cutaneous Survived 23 Crum (29) 66 Asian Female Meningitis Survived 24 Crum (29) 20 White Male Appendicular osteomyelitis Survived 25 Crum (29) 58 Asian Male Cutaneous Survived 26 Crum (29) 28 Black Male Cutaneous Survived 27 Crum (29) 23 Black Female Axial osteomyelitis Survived 28 Crum (29) 28 Black Male Axial osteomyelitis Survived 29 Crum (29) 32 White Male Cutaneous Survived 30 Crum (29) 54 Asian Male Soft tissue Survived 31 Crum (29) 56 Asian Female Appendicular osteomyelitis Survived 32 Crum (29) 66 White Female Appendicular osteomyelitis Survived 33 Crum (29) 40 Asian Male Meningitis Survived 34 Crum (29) 26 White Male Meningitis Survived 35 Crum (29) 43 Black Male Cutaneous Survived 36 Crum (29) 52 Asian Male Appendicular osteomyelitis Survived 37 Crum (29) 22 Asian Female Appendicular osteomyelitis Survived 38 Crum (29) 33 Black Male Axial osteomyelitis Survived 39 Crum (29) 25 Black Male Axial osteomyelitis Survived 40 Crum (29) 37 Black Male Appendicular osteomyelitis Survived 41 Crum (29) 46 Asian Male Appendicular osteomyelitis Survived 42 Crum (29) 22 NR Male Meningitis Survived 40 43 Crum (29) 25 Black Male Axial osteomyelitis Survived 44 Crum (29) 52 Asian Male Lymphadenitis Survived 45 Crum (29) 10 Black Female Soft tissue Survived 46 Crum (29) 51 Black Male Soft tissue Survived 47 Crum (29) 26 Asian Male Meningitis Survived 48 Crum (29) 35 Latino Male Cutaneous Survived 49 Crum (29) 1 Black Female Axial osteomyelitis Survived 50 Crum (29) 45 Asian Male Meningitis Survived 51 Crum (29) 67 Asian Male Appendicular osteomyelitis Survived 52 Crum (29) 27 White Male Appendicular osteomyelitis Survived 53 Crum (29) 20 Black Male Appendicular osteomyelitis Survived 54 Crum (29) 50 Black Male Appendicular osteomyelitis Survived 55 Crum (29) 40 NR Male Soft tissue Survived 56 Crum (29) 49 Native American Female Axial osteomyelitis Survived 57 Crum (29) 62 Black Male Soft tissue Survived 58 Crum (29) 35 White Female Meningitis Survived 59 Crum (29) 44 Asian Male Cutaneous Survived 60 Crum (29) 37 White Male Appendicular osteomyelitis Survived 61 Crum (29) 23 NR Male Axial osteomyelitis Survived 62 Werle (142) 50 Latino Male Axial osteomyelitis Survived 63 Reuss (143) 40 White Male Soft tissue Died of other causes 64 Truett (144) 65 Black Male Soft tissue Survived 65 Truett (144) 53 White Male Soft tissue Survived 66 Arnold (98) 11 Asian Female Soft tissue Survived 67 Crum (145) 21 Black Male Axial osteomyelitis Survived 68 Crum (145) 17 Black Male Appendicular osteomyelitis Survived 69 Crum (145) 24 Asian Male Cutaneous Survived Buchmiller-Crair 36 Black Male Soft tissue Survived
70 (146) 71 Kim (147) 50 White Male Cutaneous Survived 72 Rance (148) 78 White Male Cutaneous Survived 73 Shibili (149) 23 Black Male Axial osteomyelitis Survived 74 Nakamura (150) 28 Asian Male Axial osteomyelitis Survived 75 Holley (101) 21 NR Female Appendicular osteomyelitis Survived 76 Holley (101) 27 NR Male Axial osteomyelitis Survived 77 Holley (101) 69 NR Female Appendicular osteomyelitis Survived 78 Holley (101) 54 NR Male Axial osteomyelitis Survived 79 Holley (101) 35 NR Male Appendicular osteomyelitis Survived 80 Holley (101) 20 NR Male Appendicular osteomyelitis Survived 81 Holley (101) 38 NR Male Appendicular osteomyelitis Survived 82 Holley (101) 32 NR Male Axial osteomyelitis Survived 83 Holley (101) 25 NR Male Appendicular osteomyelitis Survived 84 Holley (101) 30 NR Female Axial osteomyelitis Died of other causes 85 Holley (101) 29 NR Male Axial osteomyelitis Survived 86 Robertson (151) 48 Black Male Soft tissue Survived 87 Faul (152) 20 NR Male Soft tissue Survived 88 Olivere (153) 35 White Male Soft tissue Survived 89 Smilack (58) 78 NR Male Soft tissue Survived 90 Herron (105) 27 White Male Axial osteomyelitis Survived 91 Herron (105) 45 Black Male Axial osteomyelitis Survived 92 Herron (105) 51 White Female Axial osteomyelitis Survived 93 Herron (105) 76 White Male Axial osteomyelitis Survived 94 Herron (105) 35 Black Male Axial osteomyelitis Survived 41 Odio 42 95 Herron (105) 31 Black Male Axial osteomyelitis Survived 96 Herron (105) 63 White Male Axial osteomyelitis Survived 97 Herron (105) 27 Black Male Axial osteomyelitis Survived 98 Herron (105) 50 Black Male Axial osteomyelitis Survived 99 Herron (105) 62 Native American Male Axial osteomyelitis Survived 100 Herron (105) 23 Black Male Axial osteomyelitis Survived 101 Herron (105) 55 Black Male Axial osteomyelitis Survived 102 Herron (105) 21 Black Male Axial osteomyelitis Survived 103 Banuelos (59) 36 Latino Male Meningitis Survived 104 Banuelos (59) 42 Asian Male Meningitis Survived 105 Low (154) 4 NR Female Axial osteomyelitis Survived 106 Olson (107) 24 Black Male Axial osteomyelitis Survived 107 Cardone (155) 27 Latino Male Cutaneous Survived 108 Cardone (155) 53 White Female Cutaneous Survived 109 Harley (156) 23 Black Male Cutaneous Survived 110 Bickel (157) 0 Latino Male Appendicular osteomyelitis Survived 111 Kohn (158) 33 White Male Meningitis Survived 112 Sherman (159) 22 Black Female Axial osteomyelitis Died of other causes 113 Boyle (160) 40 White Female Lymphadenitis Survived 114 Sprinkle (161) 60 Latino Male Appendicular osteomyelitis Survived 115 Kuntze (162) 34 White Male Soft tissue Survived 116 Dudley (163) 21 NR Female Soft tissue Survived 117 Dudley (163) 13 NR Female Soft tissue Survived 118 Golden (164) 0 Latino Male Soft tissue Survived 119 Dickinson (165) 34 Latino Male Cutaneous Survived 120 Moreno (166) 22 White Male Cutaneous Survived 121 Schwartz (167) 83 Black Male Cutaneous Survived 122 Davidson (168) 66 NR Male Soft tissue Survived 123 Parker (169) 25 White Female Soft tissue Survived 124 Blumenkranz (120) 24 White Male Soft tissue Survived 125 Graybill (122) 24 Black Male Appendicular osteomyelitis Survived 126 Sung (170) 62 Latino Male Soft tissue Survived 127 Igo (171) 47 White Male Axial osteomyelitis Survived 128 Meyer (124) 45 Black Male Meningitis Survived 129 Meyer (124) 57 White Male Appendicular osteomyelitis Survived 130 Lee (83) 17 NR Male Lymphadenitis Died 131 Armbuster (127) 27 Latino Male Appendicular osteomyelitis Survived 132 Armbuster (127) 41 White Male Appendicular osteomyelitis Survived 133 Armbuster (127) 61 Asian Male Appendicular osteomyelitis Survived 134 Turner (172) 37 Black Male Soft tissue Survived 135 Ward (173) 0 Latino Male Soft tissue Survived 136 Winter (130) 49 Asian Male Appendicular osteomyelitis Survived 137 Winter (130) 22 White Male Appendicular osteomyelitis Survived 138 Winter (130) 2 NR Male Appendicular osteomyelitis Survived 139 Zeller (174) 43 Black Male Cutaneous Survived
42 Supp. Table 9. Demographic information of patients with single site disseminated coccidioidomycosis (SDCM).
*Other: Not reported (28), Native American (2)
Total Survived Died Death from other cause Total, n (%) 139 135 (97) 1 (1) 3 (2) Age, years, median (IQR) 36 (24 – 52) 36 (25 – 53) 17 30 (22 – 40) Gender, Male, n (%) 115 (83) 113 (84) 1 (100) 1 (33) Race, n (%) Black 44 (32) 43 (32) 0 (0) 1 (33) White 29 (21) 28 (21) 0 (0) 1 (33) Asian 24 (17) 24 (18) 0 (0) 0 (0) Latino 12 (9) 12 (9) 0 (0) 0 (0) Other* 30 (22) 28 (21) 1 (100) 1 (33) Site of dissemination, n (%) Osteomyelitis 69 (50) 67 (50) 0(0) 2 (67) Axial 38 (27) 36 (27) 0 (0) 2 (67) Appendicular 31 (22) 31 (23) 0 (0) 0 (0) 43 Odio 44 Meningitis 13 (9) 13 (10) 0 (0) 0 (0) Lymphadenitis 4 (3) 3 (2) 1 (100) 0 (0) Cutaneous 21 (15) 21 (16) 0 (0) 0 (0) Soft tissue 32 (23) 31 (23) 0 (0) 1 (33) Year Published, n (%) 2000 - 2012 85 (61) 83 (61) 0 (0) 2 (67) 1990 - 1999 28 (20) 27 (20) 0 (0) 1 (33) 1980 - 1989 12 (9) 12 (9) 0 (0) 0 (0) 1970 - 1979 14 (10) 13 (10) 1 (100) 0 (0)
Supp. Table 10. Location of coccidioidomycosis dissemination by racial group in patients with single-site disseminated coccidioidomycosis (SDCM).
*Other: Native American (2), Not reported (28)
Total, n (%) Black White Latino Asian *Other
Total, n 139 44 29 12 24 30 Osteomyelitis 69 (50) 28 (64) 12 (41) 4 (33) 8 (33) 17 (57) Axial 38 (28) 22 (50) 5 (17) 1 (8) 1 (4) 9 (30) Appendicular 31 (22) 6 (14) 7 (24) 3 (25) 7 (29) 8 (27) Meningitis 13 (9) 1 (2) 5 (17) 1 (8) 5 (21) 1 (3) Lymphadenitis 4 (3) 0 (0) 1 (3) 0 (0) 1 (4) 2 (6) Cutaneous lesions 21 (15) 7 (16) 5 (17) 3 (25) 6 (25) 0 (0) Soft Tissue 32 (23) 8 (18) 6 (21) 4 (33) 4 (17) 10 (33)
44 References
1. MENDENHALL JC, BLACK WC, POTTZ GE. Progressive (disseminated) coccidioidomycosis during pregnancy. Rocky Mt Med J. 1948;45(6):472–6.
2. SMALE LE, BIRSNER JW. Maternal deaths from coccidioidomycosis. J Am Med Assoc. 1949;140(14):1152–4.
3. Conan J, Hyman GA. Disseminated coccidioidomycosis. Treatment with protoanemonin. Am J Med. 1950;9(3):408–13.
4. J.E. Vaughn, H. Rameriz. Coccidioidomycosis as a complication of pregnancy. Calif Med. 1951;74.
5. COHEN R. Placental coccidioides; proof that congenital coccidioides is nonexistent. Arch Pediatr. 1951;68(2):59–66.
6. Baker RL. Pregnancy complicated by coccidioidomycosis: report of two cases. Am J Obstet Gynecol. 1955;70(5):1033–8.
7. Harrison HN. Fatal maternal coccidioidomycosis. A case report and review of sixteen cases from the literature. Am J Obstet Gynecol. 1958;75(4):813–20.
8. Mongan ES. Acute disseminated coccidioidomycosis. Am J Med. 1958;24(5):820–2.
9. Harris RE. Coccidioidomycosis complicating pregnancy: Report of 3 cases and review of the literature. Obstet Gynecol. 1966;28(3):401–5.
10. Hadsall FJ, Acquarelli MJ. Disseminated coccidioidomycosis presenting as facial granulomas in pregnancy: A report of two cases and a review of the literature. Laryngoscope. 1973;83(1):51–8.
11. Purtilo DT. Opportunistic mycotic infections in pregnant women. Am J Obstet Gynecol. 1975;122(5):607–10.
12. VanBergen WS, Fleury FJ, Cheatle EL. Fatal maternal disseminated coccidioidomycosis in a nonendemic area. Am J Obstet Gynecol. 1976 Mar 15;124(6):661–3.
13. Steele RW, Sieger BE, McNitt TR, Gentry LO, Moore WL Jr. Therapy for disseminated coccidioidomycosis with transfer factor from a related donor. Am J Med. 1976 Aug;61(2):283–6.
14. Shafai T. Neonatal Coccidioidomycosis in Premature Twins. Am J Dis Child. 1978;132(6):634.
15. M.A. MaCaffree, G. Ashuler, K. Benirschlke. Placental coccidioidomycosis without fetal disease. Arch Path Lab Med. 1978;102:512–4.
16. Bernstein DI, Tipton JR, Schott SF, Cherry JD. Coccidioidomycosis in a neonate; maternal-infant transmission. J Pediatr. 1981;99(5):752–4.
17. Salgia K, Bhatia L, Rajashekaraiah KR, Zangan M, Hariharan S, Kallick CA. Coccidioidomycosis of the Uterus. South Med J. 1982;75(5):614–6.
18. Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest. 1988 Aug;94(2):376–9.
19. Babycos PB, Hoda SA. A fatal case of disseminated coccidioidomycosis in Louisiana. J La State Med Soc Off Organ La State Med Soc. 1990 Aug;142(8):24–7.
20. Lee BE, Feinberg M, Abraham JJ, Murthy ARK. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J. 1992;11(12):1062–4.
21. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis. 1996;22(2):336–40.
22. Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: Report of an additional patient. Am J Med Genet. 1997;72(3):253–6.
23. Charlton V, Ramsdell K, Sehring S. Intrauterine transmission of coccidioidomycosis. Pediatr Infect Dis J. 1999;18(6):561–3. 45 Odio 46 24. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006 Nov;119(11):993.e11–7.
25. Arnold CA, Rakheja D, Arnold MA, Peters JM, Fernandes NJ, Quintanilla NM, et al. Unsuspected, disseminated coccidioidomycosis without maternofetal morbidity diagnosed by placental examination: case report and review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008 Jun 1;46(11):e119–23.
26. Hooper JE, Lu Q, Pepkowitz SH. Disseminated coccidioidomycosis in pregnancy. Arch Pathol Lab Med. 2007 Apr;131(4):652–5.
27. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005 Jun 15;40(12):1770–6.
28. Cunningham ET Jr, Seiff SR, Berger TG, Lizotte PE, Howes EL Jr, Horton JC. Intraocular coccidioidomycosis diagnosed by skin biopsy. Arch Ophthalmol. 1998 May;116(5):674–7.
29. Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004 May;83(3):149–75.
30. Calderón Garcidueñas AL, Piña Osuna K, Cerda Flores RM. [A clinical and pathological study of coccidioidomycosis and pregnancy in four Mexican women]. Ginecol Obstet México. 2004 Sep;72:450–4.
31. Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv. 1993 Mar;48(3):149–56.
32. Bravo R, Pelayo-Katsanis LO, Shehab ZM, Katsanis E. Diagnostic and treatment challenges for the pediatric hematologist oncologist in endemic areas for coccidioidomycosis. J Pediatr Hematol Oncol. 2012 Jul;34(5):389–94.
33. Blodget E, Geiseler PJ, Larsen RA, Stapfer M, Qazi Y, Petrovic LM. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis Off J Transplant Soc. 2012 Jun;14(3):305–10.
34. Dierberg KL, Marr KA, Subramanian A, Nace H, Desai N, Locke JE, et al. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis Off J Transplant Soc. 2012 Jun;14(3):300–4.
35. Keckich DW, Blair JE, Vikram HR, Seville MT, Kusne S. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation. 2011 Jul 15;92(1):88–93.
36. Kokseng SL, Blair JE. Successful kidney transplantation after coccidioidal meningitis. Transpl Infect Dis Off J Transplant Soc. 2011 Jun;13(3):285–9.
37. Mitter SS, Derhovanessian A, Hillman JD, Uslan DZ. Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):231–5.
38. Carvalho C, Ferreira I, Gaião S, Guimarães S, Costa R, Santos J, et al. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis Off J Transplant Soc. 2010 Apr;12(2):151–4.
39. Keckich DW, Blair JE, Vikram HR. Coccidioides fungemia in six patients, with a review of the literature. Mycopathologia. 2010 Aug;170(2):107–15.
40. Trentman TL, Hoxworth JM, Kusne S, Torloni AS, Patel NP, Rosenfeld DM. Allogeneic epidural blood patch in the setting of persistent spinal headache and disseminated coccidioidomycosis. Pain Physician. 2009 Jun;12(3):639–43.
41. Wollina U, Hansel G, Vennewald I, Schönlebe J, Tintelnot K, Seibold M, et al. Successful treatment of relapsing disseminated coccidioidomycosis with cutaneous involvement with posaconazole. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2009 Jan;7(1):46–9.
42. Stagliano D, Epstein J, Hickey P. Fomite-transmitted coccidioidomycosis in an immunocompromised child. Pediatr Infect Dis J. 2007 May;26(5):454–6. 46 43. Kappel ST, Wu JJ, Hillman JD, Linden KG. Histopathologic findings of disseminated coccidioidomycosis with hyphae. Arch Dermatol. 2007 Apr;143(4):548–9.
44. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2006 Aug;12(8):1290–2.
45. Sohail MR, Andrews PE, Blair JE. Coccidioidomycosis of the male genital tract. J Urol. 2005 Jun;173(6):1978–82.
46. Ugurlu S, de Alba Campomanes AG, Naseri A, Blair JE, McLeish WM. Coccidioidomycosis of the eyelid. Ophthal Plast Reconstr Surg. 2005 Mar;21(2):157–9.
47. Wang C-Y, Jerng J-S, Ko J-C, Lin M-F, Hsiao C-H, Lee L-N, et al. Disseminated coccidioidomycosis. Emerg Infect Dis. 2005 Jan;11(1):177–9.
48. Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol. 2005 Dec;43(8):705–10.
49. Blair JE. Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. Transpl Infect Dis Off J Transplant Soc. 2004 Jun;6(2):74–6.
50. Lewicky YM, Roberto RF, Curtin SL. The unique complications of coccidioidomycosis of the spine: a detailed time line of disease progression and suppression. Spine. 2004 Oct 1;29(19):E435– 41.
51. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol. 2004 May;42(5):2347–9.
52. Kuberski TT, Servi RJ, Rubin PJ. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004 Mar 15;38(6):910–2.
53. Antony S, Dominguez DC, Sotelo E. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis. J Natl Med Assoc. 2003 Oct;95(10):982–5.
54. Wright PW, Pappagianis D, Wilson M, Louro A, Moser SA, Komatsu K, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2003 Nov 1;37(9):1265–9.
55. Yorgin PD, Rewari M, al-Uzri AY, Theodorou AA, Scott KM, Barton LL. Coccidioidomycosis in adolescents with lupus nephritis. Pediatr Nephrol Berl Ger. 2001 Jan;16(1):77–81.
56. Fishco WD, Blocher KS. Disseminated coccidioidomycosis masquerading as tendinitis. J Am Podiatr Med Assoc. 2000 Dec;90(10):508–11.
57. Erly WK, Labadie E, Williams PL, Lee DM, Carmody RF, Seeger JF. Disseminated coccidioidomycosis complicated by vasculitis: a cause of fatal subarachnoid hemorrhage in two cases. AJNR Am J Neuroradiol. 1999 Oct;20(9):1605–8.
58. Smilack JD, Argueta R. Coccidioidal infection of the thyroid. Arch Intern Med. 1998 Jan 12;158(1):89–92.
59. Bañuelos AF, Williams PL, Johnson RH, Bibi S, Fredricks DN, Gilroy SA, et al. Central nervous system abscesses due to Coccidioides species. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996 Feb;22(2):240–50.
60. Wagner JA, Keer H, Fredricks DN. Disseminated coccidioidomycosis diagnosed by culture of a central venous catheter tip. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996 Jan;22(1):180–1.
61. Mischel PS, Vinters HV. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis Off Publ Infect Dis Soc Am. 1995 Feb;20(2):400–5.
62. Gold WL, Campbell I, Vellend H. Disseminated coccidioidomycosis in a Canadian patient with chronic HIV infection--Ontario. Can Commun Dis Rep Relevé Mal Transm Au Can. 1992 Oct 16;18(19):149–50.
47 Odio 48 63. Zar FA, Fernandez M. Failure of ketoconazole maintenance therapy for disseminated coccidioidomycosis in AIDS. J Infect Dis. 1991 Oct;164(4):824–5.
64. Dodd LG, Nelson SD. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am J Clin Pathol. 1990 Jan;93(1):141–4.
65. Byrne WR, Dietrich RA. Disseminated coccidioidomycosis with peritonitis in a patient with acquired immunodeficiency syndrome. Prolonged survival associated with positive skin test reactivity to coccidioidin. Arch Intern Med. 1989 Apr;149(4):947–8.
66. Prichard JG, Sorotzkin RA, James RE 3rd. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis. 1987 Mar;39(3):203–5.
67. Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987 Nov;83(5):949–52.
68. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis. An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore). 1986 Sep;65(5):312–21.
69. Wolf JE, Little JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis. 1986 Nov;5(4):331–6.
70. Parker MS, Dokoh S, Woolfenden JM, Buchsbaum HW. Hypercalcemia in coccidioidomycosis. Am J Med. 1984 Feb;76(2):341–4.
71. Abrams DI, Robia M, Blumenfeld W, Simonson J, Cohen MB, Hadley WK. Disseminated coccidioidomycosis in AIDS. N Engl J Med. 1984 Apr 12;310(15):986–7.
72. Kovacs A, Forthal DN, Kovacs JA, Overturf GD. Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome. West J Med. 1984 Mar;140(3):447–9.
73. Howard PF, Smith JW. Diagnosis of disseminated coccidioidomycosis by liver biopsy. Arch Intern Med. 1983 Jul;143(7):1335–8.
74. Brewer JH, Parrott CL, Rimland D. Disseminated coccidioidomycosis in a heart transplant recipient. Sabouraudia. 1982 Dec;20(4):261–5.
75. MacDonald N, Steinhoff MC, Powell KR. Review of coccidioidomycosis in immunocompromised children. Am J Dis Child 1960. 1981 Jun;135(6):553–6.
76. Allen WG, Olsen GN, Yergin BM. Disseminated coccidioidomycosis with respiratory failure presenting in Florida. J Fla Med Assoc. 1981 May;68(5):365–8.
77. Gardner S, Seilheimer D, Catlin F, Anderson DC, Hernried L. Supglottic coccidioidomycosis presenting with persistent stridor. Pediatrics. 1980 Oct;66(4):623–5.
78. Kaplan JE, Zoschke D, Kisch AL. Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis. Am J Med. 1980 Apr;68(4):624–8.
79. Davis SJ, Donovan WH. Combined intravenous miconazole and intrathecal amphotericin B for treatment of disseminated coccidioidomycosis. Chest. 1979 Aug;76(2):235–6.
80. Halpern AA, Rinsky LA, Fountain S, Nagel DA. Coccidioidomycosis of the spine: unusual roentgenographic presentation. Clin Orthop. 1979 May;(140):78–9.
81. Harvey RP, Pappagianis D, Cochran J, Stevens DA. Otomycosis due to coccidioidomycosis. Arch Intern Med. 1978 Sep;138(9):1434–5.
82. Schröter GP, Bakshandeh K, Husberg BS, Well R 3rd. Coccidioidomycosis and renal transplantation. Transplantation. 1977 Jun;23(6):485–9.
83. Lee JC, Catanzaro A, Parthemore JG, Roach B, Deftos LJ. Hypercalcemia in disseminated coccidioidomycosis. N Engl J Med. 1977 Aug 25;297(8):431–3.
84. Krulig L, Jacobs PH, Loeffel D. Pemphigus vulgaris and disseminated coccidioidomycosis. Sabouraudia. 1976 Mar;14(1):5–9.
85. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine (Baltimore). 1975 Sep;54(5):377–95. 48 86. Fierer J, Burton DW, Haghighi P, Deftos LJ. Hypercalcemia in disseminated coccidioidomycosis: expression of parathyroid hormone-related peptide is characteristic of granulomatous inflammation. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012 Oct;55(7):e61–6.
87. Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis. J Infect. 2011 Sep;63(3):223–8.
88. Silva-Hernández AG, Barbachano-Rodríguez E, Alanís-Miranda PA, del Rocío González-Martínez M, Portales-Castanedo A. [Tuberculosis and coccidiodomycosis in two patients without immune acquired deficiency]. Rev Médica Inst Mex Seguro Soc. 2010 Aug;48(4):447–52.
89. Kwok HKH, Chan JWM, Li IWS, Chu SYY, Lam CW. Coccidioidomycosis as a rare cause of pneumonia in non-endemic areas: a short exposure history should not be ignored. Respirol Carlton Vic. 2009 May;14(4):617–20.
90. Wilde GE, Emery C, Lally JF. Radiological reasoning: miliary disease, vertebral osteomyelitis, and soft-tissue abscesses. AJR Am J Roentgenol. 2008 Mar;190(3 Suppl):S11–7.
91. Nolt JD, Geertsma FR. Deep solitary brain mass in a four-month-old male with disseminated coccidioidomycosis: case report. Ann N Y Acad Sci. 2007 Sep;1111:385–94.
92. Crum-Cianflone NF, Truett AA, Teneza-Mora N, Maves RC, Chun HM, Bavaro MF, et al. Unusual presentations of coccidioidomycosis: a case series and review of the literature. Medicine (Baltimore). 2006 Sep;85(5):263–77.
93. Rosendahl M, Kvinesdal B. Coccidioidomycosis with cerebral and cerebellar granulomas. Scand J Infect Dis. 2006;38(6-7):532–3.
94. Crum NF. Disseminated coccidioidomycosis with cutaneous lesions clinically mimicking mycosis fungoides. Int J Dermatol. 2005 Nov;44(11):958–60.
95. La Via WV, Koulouri S, Ross LA, Quiros JA, Mason WH. Right atrial mass in a child with disseminated coccidioidomycosis. Pediatr Infect Dis J. 2005 May;24(5):470–2.
96. Biller JA, Scheuller MC, Eisele DW. Coccidioidomycosis causing massive cervical lymphadenopathy. The Laryngoscope. 2004 Nov;114(11):1892–4.
97. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004 Oct 1;39(7):e74–7.
98. Arnold MG, Arnold JC, Bloom DC, Brewster DF, Thiringer JK. Head and neck manifestations of disseminated coccidioidomycosis. The Laryngoscope. 2004 Apr;114(4):747–52.
99. Baddley JW, Cobbs CS, Pappas PG. Surgical treatment of multiple skull abscesses associated with coccidioidomycosis. Mycoses. 2004 Feb;47(1-2):69–71.
100. Danaher PJ, Cao MK, Anstead GM, Dolan MJ, DeWitt CC. Reversible dilated cardiomyopathy related to amphotericin B therapy. J Antimicrob Chemother. 2004 Jan;53(1):115–7.
101. Holley K, Muldoon M, Tasker S. Coccidioides immitis osteomyelitis: a case series review. Orthopedics. 2002 Aug;25(8):827–31, 831–2.
102. Polesky A, Kirsch CM, Snyder LS, LoBue P, Kagawa FT, Dykstra BJ, et al. Airway coccidioidomycosis--report of cases and review. Clin Infect Dis Off Publ Infect Dis Soc Am. 1999 Jun;28(6):1273–80.
103. Koehler AP, Cheng AF, Chu KC, Chan CH, Ho AS, Lyon DJ. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. J Infect. 1998 Jan;36(1):113–5.
104. Westphal SA. Disseminated coccidioidomycosis associated with hypercalcemia. Mayo Clin Proc. 1998 Sep;73(9):893–4.
105. Herron LD, Kissel P, Smilovitz D. Treatment of coccidioidal spinal infection: experience in 16 cases. J Spinal Disord. 1997 Jun;10(3):215–22.
106. Woo JH, Lee JS, Lee DW, Jin SY, Kim DW, Lee WG. A case of disseminated coccidioidomycosis--autopsy report. J Korean Med Sci. 1996 Jun;11(3):258–64. 49 Odio 50 107. Olson PE, Bone WD, LaBarre RC, Martin CR, Utz GC, Miller LK, et al. Coccidioidomycosis in California: regional outbreak, global diagnostic challenge. Mil Med. 1995 Jun;160(6):304–8.
108. Oudiz R, Mahaisavariya P, Peng SK, Shane-Yospur L, Smith C, Baumgartner F, et al. Disseminated coccidioidomycosis with rapid progression to effusive-constrictive pericarditis. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 1995 Dec;8(6):947–52.
109. Hicks MJ, Green LK, Clarridge J. Primary diagnosis of disseminated coccidioidomycosis by fine needle aspiration of a neck mass. A case report. Acta Cytol. 1994 Jun;38(3):422–6.
110. Beard JS, Benson PM, Skillman L. Rapid diagnosis of coccidioidomycosis with a DNA probe to ribosomal RNA. Arch Dermatol. 1993 Dec;129(12):1589–93.
111. Lopez AM, Williams PL, Ampel NM. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med. 1993 Aug;95(2):236–9.
112. Schwartz DN, Fihn SD, Miller RA. Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. Clin Infect Dis Off Publ Infect Dis Soc Am. 1993 Apr;16(4):486–8.
113. Chen CH, Shih JF, Hsu YT, Perng RP. Disseminated coccidioidomycosis with lung, skin and lymph node involvement: report of a case. J Formos Med Assoc Taiwan Yi Zhi. 1991 Aug;90(8):788– 92.
114. Jitsukawa K, Sato S, Hayashi Y, Yamao H, Anzai T. Disseminated coccidioidomycosis. J Dermatol. 1990 Feb;17(2):120–6.
115. Gillespie R. Treatment of cranial osteomyelitis from disseminated coccidioidomycosis. West J Med. 1986 Nov;145(5):694–7.
116. Weisman IM, Moreno AJ, Parker AL, Sippo WC, Liles WJ. Gastrointestinal dissemination of coccidioidomycosis. Am J Gastroenterol. 1986 Jul;81(7):589–93.
117. Meyer PR, Hui AN, Biddle M. Coccidioides immitis meningitis with arthroconidia in cerebrospinal fluid: report of the first case and review of the arthroconidia literature. Hum Pathol. 1982 Dec;13(12):1136–8.
118. Burch WM, Snyderman R. Induction of cellular immunity to Coccidioides immitis after sensitization with dinitrochlorobenzene. Ann Intern Med. 1982 Mar;96(3):329–31.
119. Johnson WM. Fatal disseminated coccidioidomycosis following an intestinal bypass operation for obesity. West J Med. 1981 Oct;135(4):324–6.
120. Blumenkranz MS, Stevens DA. Endogenous coccidioidal endophthalmitis. Ophthalmology. 1980 Oct;87(10):974–84.
121. McGahan JP, Graves DS, Palmer PE. Coccidioidal spondylitis: usual and unusual radiographic manifestations. Radiology. 1980 Jul;136(1):5–9.
122. Graybill JR, Lundberg D, Donovan W, Levine HB, Rodriguez MD, Drutz DJ. Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients. Rev Infect Dis. 1980 Aug;2(4):661–73.
123. Goldstein E. Miliary and disseminated coccidioidomycosis. Ann Intern Med. 1978 Sep;89(3):365–6.
124. Meyer RD, Sattler FR, Linné SR, Ruskin J. Miconazole for treatment of disseminated coccidioidomycosis. Unfavorable experience. Chest. 1978 Jun;73(6):825–31.
125. Danoff D, Munk ZM, Case B, Finlayson M, Gold P. Disseminated coccidioidomycosis: clinical, immunologic and therapeutic aspects. Can Med Assoc J. 1978 Feb 18;118(4):390–2.
126. Thadepalli H, Salem FA, Mandal AK, Rambhatla K, Einstein HE. Pulmonary mycetoma due to Coccidioides immitis. Chest. 1977 Mar;71(3):429–30.
127. Armbuster TG, Goergen TG, Resnick D, Catanzaro A. Utility of bone scanning in disseminated coccidioidomycosis: case report. J Nucl Med Off Publ Soc Nucl Med. 1977 May;18(5):450–4.
50 128. Kaplan P, Graybill JR, Thor D. Disseminated histoplasmosis followed by disseminated coccidioidomycosis. Chest. 1977 Aug;72(2):238–41.
129. Sung JP. Treatment of disseminated coccidioidomycosis with miconazole. West J Med. 1976 Jan;124(1):61–4.
130. Winter WG Jr, Larson RK, Honeggar MM, Jacobsen DT, Pappagianis D, Huntington RW Jr. Coccidioidal arthritis and its treatment -- 1975. J Bone Joint Surg Am. 1975 Dec;57(8):1152–7.
131. Arora NP, Taneja V, ReyesSacin C, Bhanot R, Natesan SK. Coccidioidomycosis masquerading as malignancy. BMJ Case Rep. 2012;2012.
132. Kumar KSS, Narasimhan A, Gopalakrishnan R, Geetha N, Thirunarayanan MA, Suryanarayanan P. Coccidioidomycosis in Chennai. J Assoc Physicians India. 2011 Feb;59:122–4.
133. Newlon HR, Lambiase MC. Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio. Cutis. 2010 Jul;86(1):25–8.
134. Evans K, Calhoun RF, Black H, Cooke DT. Disseminated primary coccidioidomycosis of the chest wall. J Thorac Cardiovasc Surg. 2010 Nov;140(5):e78–9.
135. Reach P, Paugam A, Kahan A, Allanore Y, Wipff J. Coccidioidomycosis of the spine in an immunocompetent patient. Jt Bone Spine Rev Rhum. 2010 Dec;77(6):611–3.
136. Gaidici A, Saubolle MA. Transmission of coccidioidomycosis to a human via a cat bite. J Clin Microbiol. 2009 Feb;47(2):505–6.
137. Park DW, Sohn JW, Cheong HJ, Kim WJ, Kim MJ, Kim JH, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis. 2006;6:26.
138. Hwang JM, Pian D. Iritis presumed as secondary to disseminated coccidioidomycosis. Optom St Louis Mo. 2006 Nov;77(11):547–53.
139. Chuang A, Thomas R, Hoffman RS. Disseminated coccidioidomycosis in an immunocompetent person living in New York City. J Urban Health Bull N Y Acad Med. 2005 Jun;82(2):339–45.
140. Snyder CH. Coccidioidal meningitis presenting as memory loss. J Am Acad Nurse Pract. 2005 May;17(5):181–6.
141. Rodriguez RA, Konia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005 Jan;129(1):e4–6.
142. Werle J, Goodman S. Chronic coccidioidomycosis infection of the knee: a case report. Am J Orthop Belle Mead NJ. 2004 Aug;33(8):409–11.
143. Reuss CS, Hall MC, Blair JE, Yeo T, Leslie KO. Endocarditis caused by Coccidioides species. Mayo Clin Proc Mayo Clin. 2004 Nov;79(11):1451–4.
144. Truett AA, Crum NF. Coccidioidomycosis of the prostate gland: two cases and a review of the literature. South Med J. 2004 Apr;97(4):419–22.
145. Crum NF, Lederman ER, Hale BR, Lim ML, Wallace MR. A cluster of disseminated coccidioidomycosis cases at a US military hospital. Mil Med. 2003 Jun;168(6):460–4.
146. Buchmiller-Crair TL. Initial presentation of coccidioidomycosis during inguinal herniorrhaphy. Hernia J Hernias Abdom Wall Surg. 2003 Jun;7(2):92–4.
147. Kim A, Parker SS. Coccidioidomycosis: case report and update on diagnosis and management. J Am Acad Dermatol. 2002 May;46(5):743–7.
148. Rance BR, Elston DM. Disseminated coccidioidomycosis discovered during routine skin cancer screening. Cutis. 2002 Jul;70(1):70–2.
149. Shibli M, Ghassibi J, Hajal R, O’Sullivan M. Adjunctive corticosteroids therapy in acute respiratory distress syndrome owing to disseminated coccidioidomycosis. Crit Care Med. 2002 Aug;30(8):1896–8.
150. Nakamura H, Nakamura T, Suzuki M, Minamoto F, Oyaizu N, Shiba T, et al. Disseminated coccidioidomycosis with intra- and paravertebral abscesses. J Infect Chemother Off J Jpn Soc Chemother. 2002 Jun;8(2):178–81. 51 Odio 52 151. Robertson S, Kovitz KL, Moroz K. Disseminated coccidioidomycosis. The role of cytology in multidisciplinary clinical approach and diagnosis. J La State Med Soc Off Organ La State Med Soc. 1999 Aug;151(8):409–13.
152. Faul JL, Hoang K, Schmoker J, Vagelos RH, Berry GJ. Constrictive pericarditis due to coccidiomycosis. Ann Thorac Surg. 1999 Oct;68(4):1407–9.
153. Olivere JW, Meier PA, Fraser SL, Morrison WB, Parsons TW, Drehner DM. Coccidioidomycosis--the airborne assault continues: an unusual presentation with a review of the history, epidemiology, and military relevance. Aviat Space Environ Med. 1999 Aug;70(8):790–6.
154. Low WS, Seid AB, Pransky SM, Kearns DB. Coccidioides immitis subperiosteal abscess of the temporal bone in a child. Arch Otolaryngol Head Neck Surg. 1996 Feb;122(2):189–92.
155. Cardone JS, Vinson R, Anderson LL. Coccidioidomycosis: the other great imitator. Cutis. 1995 Jul;56(1):33–6.
156. Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis Off Publ Infect Dis Soc Am. 1994 Apr;18(4):627–9.
157. Bickel KD, Press BH, Hovey LM. Successful treatment of coccidioidomycosis osteomyelitis in an infant. Ann Plast Surg. 1993 May;30(5):462–5.
158. Kohn GJ, Linné SR, Smith CM, Hoeprich PD. Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis. 1992 Aug;15(6):527–30.
159. Sherman ME, Orr JE, Balogh K, Bardawil RG. Primary diagnosis of disseminated fungal disease by fine-needle aspiration of soft-tissue lesions. Diagn Cytopathol. 1991;7(5):536–9.
160. Boyle JO, Coulthard SW, Mandel RM. Laryngeal involvement in disseminated coccidioidomycosis. Arch Otolaryngol Head Neck Surg. 1991 Apr;117(4):433–8.
161. Sprinkle RL 3rd, Kosova LM, Tougas T, Morales LM, DeUgarte R. Disseminated coccidioidomycosis of an ankle joint. A case study. J Am Podiatr Med Assoc. 1989 Jun;79(6):300–5.
162. Kuntze JR, Herman MH, Evans SG. Genitourinary coccidioidomycosis. J Urol. 1988 Aug;140(2):370–4.
163. Dudley JE. Coccidioidomycosis and neck mass “single lesion” disseminated disease. Arch Otolaryngol Head Neck Surg. 1987 May;113(5):553–5.
164. Golden SE, Morgan CM, Bartley DL, Campo RV. Disseminated coccidioidomycosis with chorioretinitis in early infancy. Pediatr Infect Dis. 1986 Apr;5(2):272–4.
165. Dickinson A, Tschen JA, Wolf JE Jr. Coccidioidomycosis with cutaneous involvement. South Med J. 1984 Nov;77(11):1464–5.
166. Moreno AJ, Bohman VD, Hoadley SD, Gunther JS, Weisman I. The occurrence of disseminated coccidioidomycosis in a patient with Crohn’s disease. J Clin Gastroenterol. 1983 Aug;5(4):349–52.
167. Schwartz RA, Lamberts RJ. Isolated nodular cutaneous coccidioidomycosis. The initial manifestation of disseminated disease. J Am Acad Dermatol. 1981 Jan;4(1):38–46.
168. Davidson W, Sarosi GA. Disseminated blastomycosis and coccicioidomycosis in the same patient. Am Rev Respir Dis. 1981 Aug;124(2):179.
169. Parker P, Adcock LL. Pelvic coccidioidomycosis. Obstet Gynecol Surv. 1981 May;36(5):225–9.
170. Sung JP, Sun SS, Crutchlow PF. Coccidioidomycosis of the prostate gland and its therapy. J Urol. 1979 Jan;121(1):127–8.
171. Igo RM, Taylor CG, Scott AS, Jacoby JK. Coccidioidomycosis involving the mandible: report of case. J Oral Surg Am Dent Assoc 1965. 1978 Jan;36(1):72–5.
172. Turner S. Disseminated coccidioidomycosis: a case study. Nurse Pract. 1977 Apr;2(4):7–10.
173. Ward PH, Berci G, Morledge D, Schwartz H. Coccidioidomycosis of the larynx in infants and adults. Ann Otol Rhinol Laryngol. 1977 Oct;86(5 Pt 1):655–60. 52 174. Zeller NH. Coccidioidomycosis. Localized cutaneous lesions of disseminated type treated with Amphotericin B and fulguration. Rocky Mt Med J. 1967 Dec;64(12):66–71.
53 Odio